论文部分内容阅读
20%～30%慢性乙型和丙型肝炎患者发展为肝硬化,其发生肝癌的危险性比一般人群增加一百多倍。慢性乙型肝炎的预后取决于血清学检测结果和肝炎的活动度。HBeAg 阳性慢性活动性肝炎患者的预后较 HBeAg 阴性慢性迁延性肝炎患者的预后要差。因此,慢性乙肝抗病毒活疗目的之一就是持续抑
20% to 30% of patients with chronic hepatitis B and C develop cirrhosis and their risk of developing HCC is more than 100 times greater than that of the general population. The prognosis of chronic hepatitis B depends on serological test results and hepatitis activity. Patients with HBeAg-positive chronic active hepatitis have a worse prognosis than patients with HBeAg-negative chronic persistent hepatitis. Therefore, one of the purposes of chronic hepatitis B antiviral therapy is sustained suppression